Balyasny Asset Management’s Surmodics SRDX Stock Holding History

Balyasny Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-132,455	Closed	-$3.96M	–	3525
2025 Q3	$3.96M	Sell	132,455 -139,227	-51%	-$4.65M	0.01%	1481
2025 Q2	$8.07M	Buy	271,682 +2,290	+0.9%	+$66K	0.01%	1060
2025 Q1	$8.22M	Buy	269,392 +145,127	+117%	+$4.89M	0.01%	1025
2024 Q4	$4.92M	Buy	+124,265	New	+$4.83M	0.01%	1297
2018 Q3	–	Sell	-5,443	Closed	-$300K	–	2010
2018 Q2	$300K	Buy	+5,443	New	+$251K	﹤0.01%	1522

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's SRDX Position: Q4 2025 in Review

Balyasny Asset Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 132,455 shares — an estimated $3.96M sold.

Balyasny Asset Management first reported a position in SRDX in Q2 2018 and held it in 5 quarters. The position peaked at $8.22M in Q1 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Balyasny Asset Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Balyasny Asset Management sold 132,455 Surmodics shares in Q4 2025, an estimated $3.96M.
Balyasny Asset Management first reported a position in Surmodics in Q2 2018 and held it in 5 quarters.
Balyasny Asset Management's Surmodics position peaked at $8.22M in Q1 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.